{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:40:49Z","timestamp":1780814449104,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.02.001","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T13:18:15Z","timestamp":1234531095000},"page":"2089-2093","source":"Crossref","is-referenced-by-count":31,"title":["Effectiveness of Jeryl Lynn-containing vaccine in Spanish children"],"prefix":"10.1016","volume":"27","author":[{"given":"Jes\u00fas","family":"Castilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Garc\u00eda Cenoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Arriazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian","family":"Fern\u00e1ndez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Mart\u00ednez-Artola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaione","family":"Etxeberria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Irisarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Barricarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.001_bib1","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1001\/jama.284.20.2643","article-title":"Mumps and rubella eliminated from Finland","volume":"284","author":"Peltola","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.02.001_bib2","unstructured":"Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47(RR-8):1\u201357."},{"key":"10.1016\/j.vaccine.2009.02.001_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/bmj.330.7500.1119","article-title":"Mumps outbreaks across England and Wales in 2004: observational study","volume":"330","author":"Savage","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2009.02.001_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2807\/esm.10.09.00559-en","article-title":"An outbreak of mumps in Sweden, February\u2013April 2004","volume":"10","author":"Sartorius","year":"2005","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2009.02.001_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.02.001_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.02.001_bib7","series-title":"Vaccines","first-page":"452","article-title":"Mumps vaccine","author":"Plotkin","year":"2004"},{"key":"10.1016\/j.vaccine.2009.02.001_bib8","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.vaccine.2004.02.001","article-title":"Outbreak of mumps in a vaccinated child population: a question of vaccine failure?","volume":"22","author":"Vandermeulen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.001_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/infdis\/169.1.77","article-title":"Sustained transmission of mumps in a highly vaccinated population: assessment of a primary vaccine failure and waning vaccine-induced immunity","volume":"169","author":"Briss","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.001_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3201\/eid1301.060649","article-title":"Vaccine effectiveness estimates, 2004\u20132005 mumps outbreak, England","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.001_bib11","unstructured":"Centro Nacional de Epidemiolog\u00eda. Situaci\u00f3n de la parotiditis en Espa\u00f1a. Madrid: Instituto de Salud Carlos III, Junio; 2008. http:\/\/www.isciii.es\/htdocs\/centros\/epidemiologia\/epi_vacunables.jsp."},{"key":"10.1016\/j.vaccine.2009.02.001_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1157\/13116573","article-title":"Evoluci\u00f3n de los casos de parotiditis confirmados serol\u00f3gicamente en las Comunidad de Madrid durante un periodo de 7 a\u00f1os (2000\u20132006)","volume":"130","author":"Sanz","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.vaccine.2009.02.001_bib13","unstructured":"Centers for Disease Control. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(RR-10):1\u201358."},{"key":"10.1016\/j.vaccine.2009.02.001_bib14","doi-asserted-by":"crossref","unstructured":"Castilla J, Garc\u00eda Cenoz M, Irisarri F, N\u00fa\u00f1ez-C\u00f3rdoba JM, Barricarte A. Mumps outbreak in Navarre region, Spain, 2006\u20132007. Euro Survell 2007;12(2):E070215.1. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?PublicationType=W&Volume=12&Issue=7&OrderNumber=1.","DOI":"10.2807\/esw.12.07.03139-en"},{"key":"10.1016\/j.vaccine.2009.02.001_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)80726-7","article-title":"Mumps outbreak in a highly vaccinated population","volume":"119","author":"Hersh","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2009.02.001_bib16","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1016\/j.vaccine.2004.10.020","article-title":"The effectiveness of the mumps component of the MMR vaccine: a case control study","volume":"23","author":"Harling","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.001_bib17","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/S0264-410X(03)00341-4","article-title":"Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life","volume":"21","author":"Gans","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.001_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpedi.1995.02170200064010","article-title":"Mumps outbreak in a highly vaccinated school population. Evidence for large scale vaccination failure","volume":"149","author":"Cheek","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2009.02.001_bib19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0264-410X(95)00064-8","article-title":"Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up","volume":"13","author":"Davidkin","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.001_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(94)00086-3","article-title":"Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines","volume":"13","author":"Miller","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.001_bib21","unstructured":"Centres for Disease Control and Prevention. Guidelines for maintaining and managing the vaccine cold chain. MMWR Morb Mortal Wkly Rep 2003;52:1023\u20135."},{"key":"10.1016\/j.vaccine.2009.02.001_bib22","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0264-410X(00)00392-3","article-title":"Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype","volume":"19","author":"Nojd","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.001_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.aje.a116937","article-title":"Outbreaks in highly vaccinated populations: implications for studies of vaccine performance","volume":"139","author":"Fine","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.001_bib24","series-title":"Modern epidemiology","first-page":"93","article-title":"Case\u2013control studies","author":"Rothman","year":"1998"},{"key":"10.1016\/j.vaccine.2009.02.001_bib25","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/588197","article-title":"Long-term persistence of mumps antibody after receipt of 2 measles\u2013mumps\u2013rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population","volume":"197","author":"Date","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.001_bib26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:54:00Z","timestamp":1558140840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":26,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09002163"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}